Industry veteran to change gears at biotech company
Biotech firm Cpt.one is changing gears and raising its expectations by employing a new CEO - an experienced industry veteran who has worked at Pfizer, Leo Pharma and Sanofi. The company has just landed a new investment from private investors and is preparing for a phase II study of its multiple sclerosis treatment.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT
There is a lot of activity at Aarhus-based biotech company Cpt.one, which has worked to develop a new treatment for multiple sclerosis since it was founded in 2008.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
